Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

SHA:601607 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	64,136	69,396	56,107	60,072	49,277	47,493
Market Cap Growth	8.15%	23.68%	-6.60%	21.91%	3.75%	-0.60%
Enterprise Value	90,841	95,555	80,065	81,075	76,701	71,525
Last Close Price	19.18	20.68	16.07	16.63	18.09	17.06
PE Ratio	16.39	15.24	14.89	10.69	9.68	10.56
Forward PE	12.46	22.41	8.08	14.04	10.35	11.36
PS Ratio	0.23	0.25	0.22	0.26	0.23	0.25
PB Ratio	0.75	0.83	0.70	0.77	0.83	0.87
P/TBV Ratio	1.14	1.26	1.10	1.21	1.54	1.65
P/FCF Ratio	9.38	20.25	24.82	29.18	52.28	12.39
P/OCF Ratio	7.05	11.91	10.73	12.67	9.74	6.94
PEG Ratio	1.32	1.51	0.67	0.62	0.84	0.84
EV/Sales Ratio	0.33	0.35	0.31	0.35	0.36	0.37
EV/EBITDA Ratio	8.38	9.30	7.94	8.37	8.55	8.15
EV/EBIT Ratio	10.57	10.92	9.33	9.93	10.27	9.82
EV/FCF Ratio	13.29	27.89	35.41	39.39	81.38	18.65
Debt / Equity Ratio	0.70	0.65	0.65	0.57	0.69	0.67
Debt / EBITDA Ratio	5.48	4.97	4.82	4.29	4.24	3.90
Debt / FCF Ratio	8.69	15.95	22.96	21.67	43.25	9.58
Asset Turnover	1.25	1.27	1.27	1.28	1.38	1.34
Inventory Turnover	6.87	6.48	6.45	6.55	7.32	6.77
Quick Ratio	1.04	1.02	0.98	0.99	0.93	0.90
Current Ratio	1.36	1.36	1.33	1.35	1.27	1.22
Return on Equity (ROE)	6.74%	7.16%	6.53%	10.20%	11.03%	10.77%
Return on Assets (ROA)	2.42%	2.52%	2.61%	2.82%	2.99%	3.18%
Return on Capital (ROIC)	3.81%	4.04%	4.21%	4.59%	4.88%	5.19%
Return on Capital Employed (ROCE)	9.00%	9.20%	9.60%	9.30%	10.40%	11.90%
Earnings Yield	6.77%	6.56%	6.72%	9.35%	10.34%	9.47%
FCF Yield	10.66%	4.94%	4.03%	3.43%	1.91%	8.07%
Dividend Yield	3.03%	1.79%	2.55%	3.67%	2.32%	2.81%
Payout Ratio	81.44%	79.16%	105.66%	55.08%	52.54%	53.79%
Buyback Yield / Dilution	-0.48%	-0.07%	-6.28%	-22.54%	-	-
Total Shareholder Return	2.57%	1.71%	-3.72%	-18.87%	2.32%	2.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.